Abbott Laboratories (ABT): EXECUTIVE VICE PRESIDENT sold ~$406K

~$406K

Approx. value · 3,500 sh @ $116.00

101K

Holds after · shares reported

Traded

Nov 5, 2026

Filed

Nov 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 10, 2026FDARecall: Amplatzer Amulet Left Atrial Appendage Occluder Model Numbers 1. 9-ACP2-007-016 2. 9-ACP2-007-018 3. 9-ACP2-007-020 4. 9-ACP2-007-022 5. 9-ACP2-010-025 6. 9-AC…
2. Sep 17, 2026FDAFDA device clearance: EnSite™ X EP System
3. Sep 17, 2026CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
4. Sep 18, 2026CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
5. Sep 23, 2026FDAFDA device clearance: Anti-HCV Next
6. Oct 2, 2026CongressDisclosed sale of ABT — reported range $50,001 - $100,000
7. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
8. Oct 27, 2026FDAFDA device approval: Amplatzer Paraclose PVL Occluder
9. Nov 5, 2026 · this disclosureInsiderOfficer sold ~$406K of ABT shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Mary K Moreland, EXECUTIVE VICE PRESIDENT

• SEC Form 4 at Abbott Laboratories (ABT)Mar 4, 2026
• SEC Form 4 at Abbott Laboratories (ABT)Mar 5, 2025

The full history of Mary K Moreland, EXECUTIVE VICE PRESIDENT is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Abbott Laboratories

• SEC Form 144Nov 5, 2026
• House Clerk periodic transaction reportOct 30, 2026
• House Clerk periodic transaction reportOct 27, 2026
• House Clerk periodic transaction reportOct 12, 2026
• SEC Form 4Sep 3, 2026
• SEC Form 144Sep 2, 2026

Everything OQRO holds on this company is on its ABT page.